Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors - Lee,E.; Lindo,T.; Jackson,N. (Am J Respir Crit Care Med, 1999)